CONDITIONS FOR RIKSBANK REVERSED AUCTIONS SEK MUNICIPAL BONDS
|Anbudsförfarande kommuner och regioner, 2022-01-18|
|Bonds||Floating-rate Notes(FRN) issued in SEK by Municipalities or Regions with maturity in:|
The following issuers are accepted for delivery:
Delivery may not be made in Bonds purchased by the Counterparty from the issuer less than one week prior to the date for announcing the Specific terms, i.e. the purchase may not have been made after:
|Bids||Bids are made to tel 08-696 69 70 and confirmed in writing by a filled-in Bid form by e-mail to EOL@riksbank.se|
|Bid times||10.00-11.00 (CET/CEST) on the Bid date|
|Requested volume (corresponding nominal amount)||SEK 750 +/- 750 million|
|Highest permitted bid volume (corresponding nominal amount)||The total bid volume from one Counterparty for the two Credit rating classes may not exceed SEK 750 million.|
No bid may contain Bonds exceeding SEK 750 million issued by Stockholms Stad, Region Stockholm (Stockholms läns landsting) or Göteborgs Stad.
For other issuers, bids may not contain Bonds exceeding SEK 100 million issued by the same issuer.
|Lowest permitted bid volume (corresponding nominal amount)||The total bid volume from one Counterparty should not be less than SEK 50 million and not be less than SEK 5 million per Bond (ISIN code).|
|Credit rating classes||The requested volume is divided into two credit rating classes. Credit rating refers to the issuer’s credit rating. If there are credit ratings from several credit rating agencies the highest of these will be applied.|
Class 1: A long-term credit rating of AAA with S&P, Aaa with Moody’s or AAA with Fitch.
Class 2: A long-term credit rating of AA+ with S&P, Aa1 with Moody’s or AA+ with Fitch.
|Maturity||Bonds maturing between January 1. 2024 and December 31. 2024. The year is divided into four quarters and bids are placed for each quarter and Credit Class.|
Example: For Credit Class 1 with maturity quarter 2, a bid of SEK 90 million is placed at interest x %.
|Expected allocation time||Not later than 11.30 (CET/CEST) on the Bid date|
|Delivery and payment date||2022-01-20|
|Delivery of bonds||Bonds issued in the PM section:|
To the Riksbank's account in Euroclear Sweden AB's securities settlement system: 1 4948 6383.
Bonds issued in the AM section:
To the Riksbank's account at the Global Custodian State Street:
Global Custodian BIC Code: SBOSUS3CXXX
Local Settlement Agent: SKANDINAVISKA ENSKILDA BANKEN AB (SEB)
Local Settlement Agent BIC Code: ESSESESSXXX
Global Custodian's Account Name at SEB: STATE STREET BANK & TRUST
Global Custodian's Account Number at SEB: 01-100 386 491
Riksbank's Account Name at the Global Custodian: SVERIGES RIKSBANK Riksbank's Account Number at the Global Custodian: 0145
PSET BIC: VPCSSESSXXX
Counterparties must use BIC: ESSESESSXXX in field 95P::DEAG/REAG and State Street BIC: SBOSUS3CXXX in field 95P::SELL/BUYR in the settlement instruction.
Bonds issued for the euro market (ISIN code with XS):
To the Riksbank's account at Euroclear Bank: 91181.
|General terms and conditions||General terms and conditions for the Riksbank´s purchases of bonds via bid procedures 2020:3. dated 20 November 2020 (see the Riksbank´s web).|
This is a translation of the special terms and conditions published on www.riksbank.se. In the case of any inconsistency between the English translation and the Swedish language version, the Swedish language version shall prevail. Complete terms and conditions can be retrieved at www.riksbank.se.To view this piece of content from www.globenewswire.com, please give your consent at the top of this page.
To view this piece of content from ml-eu.globenewswire.com, please give your consent at the top of this page.
About GlobeNewswire by notified
One Liberty Plaza - 165 Broadway
NY 10006 New York
GlobeNewswire by notified is one of the world's largest newswire distribution networks, specializing in the delivery of corporate press releases financial disclosures and multimedia content to the media, investment community, individual investors and the general public.
Subscribe to releases from GlobeNewswire by notified
Subscribe to all the latest releases from GlobeNewswire by notified by registering your e-mail address below. You can unsubscribe at any time.
Latest releases from GlobeNewswire by notified
Mainz Biomed and Dante Genomics Announce Full Commercial Availability of ColoAlert in Italy and the United Arab Emirates16.8.2022 09:01:00 CEST | Press release
– ColoAlert to be marketed through Dante’s extensive database and sold via its region-specific, ecommerce websites – BERKELEY, Calif. and MAINZ, Germany and NEW YORK, Aug. 16, 2022 (GLOBE NEWSWIRE) -- Mainz Biomed N.V. (NASDAQ:MYNZ) (“Mainz'' or the “Company”), a molecular genetics diagnostic company specializing in the early detection of cancer, and Dante Genomics, a global leader in genomics and precision medicine, announced today the formal commencement of ColoAlert’s consumer commercial program in Italy and the United Arab Emirates (UAE). ColoAlert is Mainz’s flagship product, a highly efficacious and easy to use, at-home detection test for colorectal cancer (CRC) currently being commercialized across Europe and select international markets. With the ColoAlert test CE-IVD certified and patient collection kit CE marked to the latest IVDR requirements, ColoAlert will now be marketed through Dante’s extensive database and sold via Dante’s, region-specific, ecommerce websites. “This is
Cody Patrick Named OEM Direct Sales Manager for Nikkiso Clean Energy and Industrial Gases Group16.8.2022 09:01:00 CEST | Press release
TEMECULA, Calif., Aug. 16, 2022 (GLOBE NEWSWIRE) -- Nikkiso Cryogenic Industries’ Clean Energy & Industrial Gases Group (“Group”), a part of the Nikkiso Co., Ltd (Japan) group of companies, is pleased to announce that Cody Patrick has been named OEM Direct Sales Manager for Nikkiso ACD, a part of the Cryogenic Pumps unit of Nikkiso’s Clean Energy & Industrial Gases Group. Cody is a graduate of Texas A&M College of Engineering’s Industrial Distribution program. The combination of his education and experience with Cryogenic pumps for the industrial gases market, make him well suited to assist with growing the U.S. market. He will manage and develop business strategies and opportunities as well as assist with the development of training and educational programs for the Group’s clients. Cody will be based in Houston and report to Ian Guthrie, Business Line Manager for the Group’s Cryogenic Pumps unit. “Given Cody’s enthusiasm and understanding of the cryogenic pumps market we are excited t
Ahold Delhaize share buyback update16.8.2022 08:00:00 CEST | Press release
Zaandam, the Netherlands, August16, 2022 – Ahold Delhaize has repurchased 254,408 of its common shares in the period from August 8, 2022 up to and including August 12, 2022. The shares were repurchased at an average price of € 27.21 per share for a total consideration of € 6.9 million. These repurchases were made as part of the € 1 billion share buyback program announced on November 15, 2021. The total number of shares repurchased under this program to date is 20,621,088 common shares for a total consideration of € 561.6 million. Download the share buyback transactions excel sheet for detailed individual transaction information from https://www.aholddelhaize.com/en/investors/share-buyback-programs/2022/ This press release is issued in connection with the disclosure and reporting obligation set out in Article 2(2) of the EU Regulation that contains technical standards for buyback programs.
Sanionas Kv7-program för epilepsi avanceras till leadoptimering16.8.2022 08:00:00 CEST | Pressemelding
PRESSMEDDELANDE 16 augusti 2022 Saniona (OMX: SANION), ett biofarmaceutiskt företag med klinisk utveckling, meddelar idag att bolaget har avancerat sitt lovande Kv7-program för epilepsi till fasen leadoptimering – den sista fasen av läkemedelsupptäckt innan en klinisk kandidat väljs ut. Thomas Feldthus, VD: ”Vi tror att vi har löst knäckfrågorna för att utveckla nästa generation av läkemedelskandidater av den här klassen, och vi ser en betydande potential att ta fram nya banbrytande epilepsibehandlingar. Finansiellt kan uppsidan vara avsevärd, att döma av vissa viktiga läkemedelsavtal som nyligen slutits på Kv7-området.” Miljontals människor runt om i världen påverkas i dag av epilepsi, en sjukdom som kännetecknas av återkommande krampanfall. Det medicinska behovet är stort, eftersom omkring 30 procent av patienterna inte svarar på behandling med konventionella läkemedel mot epilepsi. Läkemedel mot kramper kan desutom ha funktionshämmande biverkningar, som ofta måste minimeras genom no
Saniona progresses its Kv7 epilepsy program into Lead Optimization16.8.2022 08:00:00 CEST | Press release
PRESS RELEASE August 16, 2022 Saniona (OMX: SANION), a clinical stage biopharmaceutical company, today announced that it has progressed its promising Kv7 epilepsy program into the Lead Optimization Phase, which is the last drug discovery phase before potential selection of a clinical candidate. Thomas Feldthus, CEO: “We believe that we have cracked the main challenges for making the next generation drug candidates of this class and see significant potential for delivering new breakthrough epilepsy treatments. The financial upside could be substantial based on very significant pharma deals recently executed in the Kv7 field”. Epilepsy, characterized by recurrent seizures, currently affects millions of people worldwide. There is a significant medical need as approximately 30% of patients are insensitive to treatment by conventional epilepsy medicines. Furthermore, anti-seizure therepy may cause disabling side effects and often require careful dose adjustment to minimize these. Kv7 ion ch